A Study of MM-111 in Patients With Advanced Her2 Positive Cancers
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2009 |
| End Date: | July 2011 |
A Phase 1-2 and Pharmacologic Study of MM-111 in Patients With Advanced, Refractory Her2 Positive Cancers
This study is an open-label Phase 1-2 trial of MM-111.
Phase 1: Patients with any solid tumor type may be enrolled to evaluate the safety and
tolerability of MM-111.
Phase 2: The Phase 2 portion of the trial is intended to serve as an exploratory study to
assist in the design of future trials.
We found this trial at
2
sites
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
Click here to add this to my saved trials
Click here to add this to my saved trials